Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2016 - 2025)
Rigel Pharmaceuticals (RIGL) has 16 years of Other Working Capital Changes data on record, last reported at $3.4 million in Q4 2025.
- For Q4 2025, Other Working Capital Changes rose 1971.27% year-over-year to $3.4 million; the TTM value through Dec 2025 reached $11.8 million, up 1812.14%, while the annual FY2025 figure was $11.8 million, 1812.14% up from the prior year.
- Other Working Capital Changes reached $3.4 million in Q4 2025 per RIGL's latest filing, down from $7.5 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $13.2 million in Q1 2025 and bottomed at -$12.2 million in Q2 2025.
- Average Other Working Capital Changes over 5 years is -$37300.0, with a median of -$286500.0 recorded in 2023.
- The widest YoY moves for Other Working Capital Changes: up 7927.38% in 2025, down 7078.82% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$2.2 million in 2021, then surged by 373.13% to $6.1 million in 2022, then plummeted by 117.81% to -$1.1 million in 2023, then surged by 83.36% to -$181000.0 in 2024, then soared by 1971.27% to $3.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $3.4 million in Q4 2025, $7.5 million in Q3 2025, and -$12.2 million in Q2 2025.